SPONSOR
CHU de Quebec-Universite Laval
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Postoperative PainReccurent/Metastatic Solid Tumor DiseaseProstate Cancer (Post Prostatectomy)Prostate CancerProstatic NeoplasmsNeoplasm Recurrence, LocalBiochemical Recurrence of Malignant Neoplasm of Prostate
CHU de Quebec-Universite Laval is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Postoperative Pain, Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy), Prostate Cancer.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — CHU de Quebec-Universite Laval
How many clinical trials has CHU de Quebec-Universite Laval sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by CHU de Quebec-Universite Laval, of which 3 are actively recruiting participants. These trials cover conditions including Postoperative Pain, Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CHU de Quebec-Universite Laval research focus on?
CHU de Quebec-Universite Laval clinical trials span Postoperative Pain, Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy), Prostate Cancer, Prostatic Neoplasms, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a CHU de Quebec-Universite Laval clinical trial?
To participate in a CHU de Quebec-Universite Laval trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CHU de Quebec-Universite Laval trials with current recruitment status updated daily.
Clinical Trials by CHU de Quebec-Universite Laval
NCT06276257
Recruiting
Paravertebral Block for Mastectomy With Immediate Reconstruction
Postoperative Pain
NCT07483658
Recruiting
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
Reccurent/Metastatic Solid Tumor Disease
NCT06052683
Recruiting
A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology